New anesthetic HSK3486 put to the test: will it be safer than propofol?
NCT ID NCT07404306
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether a new anesthetic drug called HSK3486 has abuse potential similar to or lower than propofol, a common anesthetic. It involved 43 healthy adults who occasionally use depressant drugs recreationally. The goal was to find the right dose and compare how the drugs make people feel, to help guide future safe use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HSK3486
- What this could lead to
- If successful, this could help determine whether HSK3486 is a safer anesthetic with lower abuse potential than current options.
- What could go wrong
- This is an early Phase 1 study with only 43 healthy volunteers, not patients. Results may not predict real-world abuse or safety in surgical settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERAL ANESTHESIA are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ICON (LPRA) - Salt Lake
Salt Lake City, Utah, 84124, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a targeted nerve block cut opioid use in High-Risk C-Sections?
- Can a new sedative make anesthesia safer for seniors?
- Can a lighter sedative dose keep patients calm after nasal surgery?
- A dab of gel on the breathing tube might spare surgery patients a sore throat — a trial puts it to the test.
- Could a tiny Pre-Dose of muscle relaxant make anesthesia safer and faster?
- Which intubation tool works best? trial puts three devices Head-to-Head